← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 30, 2010Last known activity
Jun 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (10)
- NCT05303818Lead sponsorPhase 4Jun 1, 2022
- NCT05303818Reponsible party - principal investigatorPhase 4Jun 1, 2022
- NCT02704598Reponsible party - principal investigatorN/AOct 1, 2014
- NCT02704598Overall official - principal investigatorN/AOct 1, 2014
- NCT02704598Lead sponsorN/AOct 1, 2014
- NCT01693809Reponsible party - principal investigatorPhase 4Jan 1, 2012
- NCT01693809Study chairPhase 4Jan 1, 2012
- NCT01693809Lead sponsorPhase 4Jan 1, 2012
- NCT01693809Overall official - principal investigatorPhase 4Jan 1, 2012
- NCT02414906CollaboratorPhase 2Jun 30, 2010
Details
- Last known activity
- Jun 1, 2022